Table 2.
Clinical characteristics of participants with persistent normal aortic root (AR) diameter and with new AR dilatation categorized in three groups according to absolute AR diameter, AR indexed to body surface area (BSA) and AR indexed to height
| No new AR dilatation | New AR dilatation | p value | No new AR/BSA dilatation | New AR/BSA dilatation | p value | No new AR/height dilatation | New AR/height dilatation | p value | |
|---|---|---|---|---|---|---|---|---|---|
| N | 386 | 66 | 423 | 34 | 419 | 42 | |||
| Age, years | 40.35 ± 9.57 | 44.45 ± 9.16 | 0.0013 | 40.77 ± 9.63 | 45.8 ± 8.64 | 0.0033 | 40.46 ± 9.54 | 46.92 ± 7.99 | < .0001 |
| BMI, Kg/m2 | 24.07 ± 3.5 | 25 ± 3.01 | 0.0424 | 24.36 ± 3.5 | 23.79 ± 3 | 0.3601 | 24.12 ± 3.42 | 25.34 ± 3.58 | 0.0299 |
| Male, % | 178 (46.11%) | 40 (60.61%) | 0.0295 | 201 (47.52%) | 22 (64.71%) | 0.0537 | 201 (47.97%) | 23 (54.76%) | 0.4012 |
| Office SBP, mmHg | 121.33 ± 14.7 | 124.33 ± 16.57 | 0.1333 | 121.45 ± 14.86 | 126.35 ± 15.95 | 0.0661 | 121.38 ± 14.63 | 126.19 ± 17.15 | 0.0462 |
| Office DBP, mmHg | 79.89 ± 9.63 | 83.03 ± 9.95 | 0.0151 | 80.16 ± 9.6 | 83.47 ± 10.58 | 0.0555 | 80.01 ± 9.57 | 84.1 ± 10.33 | 0.0092 |
| Office PP, mmHg | 41.45 ± 9.2 | 41.3 ± 10.75 | 0.9097 | 41.3 ± 9.43 | 42.1 ± 8.33 | 0.3427 | 41.37 ± 9.34 | 42.1 ± 10 | 0.6314 |
| Office HR, b/min | 70.86 ± 9.34 | 68.36 ± 9.57 | 0.0458 | 70.42 ± 9.48 | 69.76 ± 10.44 | 0.7008 | 70.56 ± 9.46 | 68.48 ± 9.63 | 0.1755 |
| 24 h SBP, mmHg | 115.79 ± 8.91 | 117.39 ± 9.86 | 0.1842 | 116.05 ± 9.03 | 115.31 ± 9.06 | 0.6468 | 115.88 ± 8.97 | 117.65 ± 9.71 | 0.2269 |
| 24 h DBP, mmHg | 72.62 ± 6.45 | 75.31 ± 7.12 | 0.0022 | 72.94 ± 6.59 | 74.4 ± 6.5 | 0.2150 | 72.76 ± 6.52 | 76.17 ± 6.7 | 0.0014 |
| 24 h PP, mmHg | 43.16 ± 4.87 | 42.08 ± 4.95 | 0.0976 | 43.07 ± 4.88 | 40.66 ± 4.51 | 0.0115 | 43.13 ± 4.88 | 41.49 ± 4.71 | 0.0381 |
| 24 h HR, b/min | 76.42 ± 8.22 | 75.66 ± 8.64 | 0.4928 | 76.33 ± 8.48 | 74.76 ± 7.94 | 0.2971 | 76.24 ± 8.36 | 76.23 ± 8.91 | 0.9925 |
| Antihypertensive drugs, % | 22 (5.74%) | 2 (3.03%) | 0.5547 | 28 (6.62%) | 1 (2.94%) | 0.7129 | 25 (6.01%) | 2 (4.76%) | 1.0000 |
| ARD, cm | 2.97 ± 0.3 | 3.32 ± 0.25 | < 0.0001 | 3.02 ± 0.33 | 3.28 ± 0.33 | < 0.0001 | 3.01 ± 0.32 | 3.32 ± 0.31 | < 0.0001 |
| ARD follow-up, cm | 3.16 ± 0.31 | 3.83 ± 0.28 | < 0.0001 | 3.23 ± 0.37 | 3.81 ± 0.4 | < 0.0001 | 3.21 ± 0.35 | 3.88 ± 0.34 | < 0.0001 |
| ARD, cm/m2 | 1.74 ± 0.16 | 1.82 ± 0.17 | 0.0001 | 1.74 ± 0.16 | 1.89 ± 0.15 | < 0.0001 | 1.74 ± 0.16 | 1.87 ± 0.17 | < 0.0001 |
| ARD follow-up, cm/m2 | 1.8 ± 0.18 | 2.06 ± 0.18 | < 0.0001 | 1.81 ± 0.18 | 2.24 ± 0.11 | < 0.0001 | 1.8 ± 0.18 | 2.17 ± 0.16 | < 0.0001 |
| ARD, cm/m | 1.8 ± 0.16 | 1.96 ± 0.14 | < 0.0001 | 1.82 ± 0.17 | 1.97 ± 0.16 | < 0.0001 | 1.82 ± 0.16 | 1.99 ± 0.16 | < 0.0001 |
| ARD follow-up, cm/m | 1.92 ± 0.16 | 2.27 ± 0.11 | < 0.0001 | 1.95 ± 0.19 | 2.31 ± 0.15 | < 0.0001 | 1.94 ± 0.17 | 2.36 ± 0.1 | < 0.0001 |
| Total cholesterol, mg/dL | 211.62 ± 38.39 | 220.15 ± 51.33 | 0.1165 | 212.65 ± 40.63 | 215.97 ± 41.2 | 0.6469 | 211.66 ± 39.23 | 222.4 ± 52.28 | 0.1025 |
| HDL cholesterol, mg/dL | 56.99 ± 14.61 | 57.05 ± 19.78 | 0.9810 | 56.47 ± 14.53 | 59.81 ± 23.07 | 0.2221 | 56.94 ± 14.79 | 55.95 ± 20.75 | 0.6894 |
| Glycemia, mg/dL | 85.67 ± 11.38 | 88.75 ± 15.71 | 0.0887 | 85.85 ± 11.25 | 91.53 ± 19.83 | 0.0347 | 85.64 ± 11.07 | 91.31 ± 18.73 | 0.0154 |
| Triglycerides, mg/dL | 95.15 ± 54.09 | 101.48 ± 54.15 | 0.1462 | 96.37 ± 54.44 | 96.47 ± 47.26 | 0.6421 | 94.63 ± 52.61 | 107.71 ± 62.86 | 0.1078 |
| LVH, % | 19 (5.38%) | 3 (4.84%) | 1.0000 | 21 (5.34%) | 2 (6.25%) | 0.6883 | 21 (5.44%) | 2 (5.26%) | 1.0000 |
| LVMI, g/m2 | 78.85 ± 16.75 | 84.19 ± 16.21 | 0.0204 | 79.69 ± 16.81 | 85.29 ± 18.12 | 0.0722 | 79.6 ± 16.82 | 83.48 ± 18.01 | 0.1781 |
For abbreviations see Table 1